Galera Therapeutics, Inc. (GRTX)
OTCMKTS · Delayed Price · Currency is USD
0.0200
-0.0016 (-7.41%)
Aug 29, 2025, 3:26 PM EDT
Galera Therapeutics Employees
Galera Therapeutics had 3 employees as of December 31, 2024. The number of employees decreased by 4 or -57.14% compared to the previous year.
Employees
3
Change (1Y)
-4
Growth (1Y)
-57.14%
Revenue / Employee
n/a
Profits / Employee
-$4,393,000
Market Cap
1.51M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3 | -4 | -57.14% |
Dec 31, 2023 | 7 | -24 | -77.42% |
Dec 31, 2022 | 31 | 1 | 3.33% |
Dec 31, 2021 | 30 | -8 | -21.05% |
Dec 31, 2020 | 38 | 6 | 18.75% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Elite Pharmaceuticals | 68 |
Tian'an Technology Group | 8 |
Glass House Brands | 374 |
Northwest Biotherapeutics | 25 |
CytoDyn | 13 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Longduoduo Company | 49 |
Galera Therapeutics News
- 8 months ago - Galera Therapeutics completes acquisition of Nova Pharmaceuticals - GlobeNewsWire
- 1 year ago - Galera Announces Board Approval of Complete Liquidation and Dissolution - GlobeNewsWire
- 1 year ago - Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates - GlobeNewsWire
- 1 year ago - Galera Adopts Limited Duration Stockholder Rights Agreement - GlobeNewsWire
- 1 year ago - Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates - GlobeNewsWire
- 1 year ago - Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates - GlobeNewsWire
- 1 year ago - Galera Announces Receipt of Type A Meeting Minutes and Strategic Update - GlobeNewsWire
- 2 years ago - Galera Schedules Type A Meeting with FDA to Discuss Next Steps for Avasopasem - GlobeNewsWire